Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: There is not established treatment pathway in advanced bronchial neuroendocrine tumours(bNETs).
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Koffas A
Authors: Koffas A, Popat R, Mohmaduvesh M, Quigley A, Navalkissoor S,
Keywords: PRRT,bronchial NETs,
Introduction: Somatostatin Analogues (SSAs) are considered the gold standard treatment in Neuroendocrine Tumours (NETs) and carcinoid syndrome.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Koffas A
Authors: Koffas A, Popat R, Dimitriou G, Quigley A, Navalkissoor S,
Keywords: PRRT, carcinoid syndrome,
Introduction: Peptide Receptor Radionuclide Therapy (PRRT) is an effective treatment option for advanced Neuroendocrine Tumours (NET), however long term survival data is lacking.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Yalchin M, Oliveira A, Pencharz D, Navalkissoor S, Quigley A,
Introduction: PRRT is an effective treatment option for advanced Neuroendocrine Tumours
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Yalchin M, Gertner J, Navalkissoor S, Quigley A, Meyer T,
Keywords: PRRT VIP,
Introduction: Radionuclide therapy has been used to treat patients with progressive/metastatic paragangliomas (PGGs) and pheochromocytomas (PCCs). To date, there is no study comparing (131)I-MIBG and peptide receptor radionuclide treatment (PRRT) in those patients.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Nastos K, Toumpanakis C, Cheung V, Navalkissoor S, Quigley A,
Keywords: paraganglioma, pheochromocytoma, (131)I-MIBG, PRRT,